High Tech Pharm Co., Ltd. (KOSDAQ:106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,800
-290 (-1.80%)
At close: Feb 27, 2026
Market Cap168.00B +2.8%
Revenue (ttm)75.60B -7.3%
Net Income11.98B -17.7%
EPS1,122.62 -45.3%
Shares Out10.63M
PE Ratio14.07
Forward PEn/a
Dividend150.00 (0.95%)
Ex-Dividend DateDec 29, 2025
Volume21,832
Average Volume63,205
Open15,820
Previous Close16,090
Day's Range15,730 - 16,260
52-Week Range10,700 - 17,800
Beta0.49
RSI66.01
Earnings DateFeb 5, 2026

About High Tech Pharm

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2024, High Tech Pharm's revenue was 77.51 billion, an increase of 0.97% compared to the previous year's 76.77 billion. Earnings were 13.71 billion, an increase of 69.75%.

Financial Statements